Catalyst Wire Dossier Catalyst Wire Dossier

SNC-109 CAR-T Cells Therapy

SNC-109 CAR-T · Shanghai Simnova Biotechnology Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SNC-109 CAR-T Cells Therapy, covering 2024-09-27 to 2024-09-27. Get the full timeline:

Most recent: Clinical Trial Update: The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM [Phase 1]

See pricing